Amendment No. 2 to the Commercialization and Reference Laboratory AgreementCommercialization and Reference Laboratory Agreement • November 6th, 2024 • Personalis, Inc. • Services-medical laboratories
This Amendment No. 2 (“Amendment”) is made as of the date of the last signature below (“Amendment Date”) between Personalis, Inc. (“Personalis”) and Tempus AI, Inc. f/k/a Tempus Labs, Inc. (“Tempus”) and amends that certain Commercialization and Reference Laboratory Agreement with the effective date of November 25, 2023 (as previously amended, the “Agreement”). Tempus and Personalis are each a “Party” and together the “Parties.”
